Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Reiterates Lack of Basis for Mexico’s Ban on…
Seed technology companies comply with Mexico’s biosafety regulations, and Mexico should do the same, BIO said today in its response to the panel set up to determine if Mexico’s ban on imports of genetically modified corn violate its commitments…
Learn more
Biotechnology is a national security Imperative,…
BIO President & CEO John F. Crowley announced today that BIO would take several important steps to reaffirm the organization’s position with regards to national security and the role that the industry plays as a vital strategic asset: “As a…
Learn more
WTO 13th Ministerial Conference outcome "positive…
Following the conclusion of the WTO 13th Ministerial Conference in Abu Dhabi, John Murphy -- BIO's Chief Policy Officer -- made the following statement: “We are encouraged that WTO Members did not agree to extend an intellectual property…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
More than 135 Emerging Biotech Leaders Urge Congress to Reject H.R. 3
December 5, 2019
More than 135 Emerging Biotech Leaders Urge Congress to Reject H.R. 3  “Our continued success depends on maintaining an environment that supports investment in tomorrow’s discoveries.” Washington, DC: December 5, 2019 – In a letter addressed…
Green Energy Solutions Unleashed Through New Partnership
November 21, 2019
Washington, D.C. (November 21, 2019) – Today, the Biotechnology Innovation Organization and the Low Carbon Fuels Coalition (LCFC) announced a new joint initiative to drive adoption of low carbon fuel policies in states. Both groups will work…
Speaker Pelosi’s Drug Pricing Plan Could Result in 56 Fewer New Medicines Over 10 Years
November 21, 2019
Washington, D.C. (November 21, 2019) — Speaker Nancy Pelosi’s Lower Drug Costs Now Act of 2019, H.R.3, could result in at least 56 fewer new medicines for patients over 10 years, according to a new analysis from economic…
America’s Bioeconomy Plays Critical Role in Feeding, Fueling, and Healing the World
October 22, 2019
“What has set the U.S. biotech sector apart has been thoughtful, bipartisan public policy approaches that create a favorable climate in which to undertake the lengthy and risky job of investing in and developing the next biotech breakthroughs.”
Proposed CFIUS Regulations Threaten Investment in America’s Life Sciences
October 21, 2019
“BIO fully supports the role of CFIUS in ensuring appropriate national security screening of certain foreign investments, but any rules must not discourage the entrepreneurial spirit that has made America the global leader in biopharmaceutical…
Nonpartisan Budget Experts Warn Speaker Pelosi’s Drug Pricing Bill will Stifle the Development of New Medicines
October 14, 2019
BIO’s President and CEO Jim Greenwood issued the following statement after the Congressional Budget Office released an analysis confirming that H.R. 3 will lead to fewer new medicines for patients.
Biotechnology Innovation Organization Announces 2021 Leadership Transition
October 8, 2019
WASHINGTON – The Biotechnology Innovation Organization (BIO) today announced that industry veteran Jim Greenwood will step down as President and CEO of the world’s largest biotechnology organization after the 2020 election and help transition a new…
RFS Proposal Supports Green Energy Breakthroughs
October 4, 2019
The Biotechnology Innovation Organization (BIO) today released the following statement on the administration’s proposal on the Renewable Fuel Standard. The following statement may be attributed to Stephanie Batchelor, vice president of BIO's…
New Executive Order Critical to Protecting Patients and Public Health
September 20, 2019
President Trump has signed an executive order focused on spurring the development of new vaccine technologies, prioritizing the production of influenza vaccines and identifying strategies for communicating the importance of influenza vaccination…
Speaker Pelosi’s Drug Pricing Plan “Crushes the Desperate Hopes of Patients and their Families”
September 19, 2019
Washington, D.C. (September 19, 2019) – Former Congressman Jim Greenwood, the President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after Speaker Nancy Pelosi and Democratic leaders in the House of…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today